Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think Ehrlich has mentally shuttered IPIX, and is waiting expectantly for the inevitable SEC suspension and subsequent delisting.
As IPIX is a limited company he will have no personal liability for the approximately $1.5 million owed to Cummings, and he will use the resulting bankruptcy to explain why shareholders receive nothing once the company is wound up (shareholders are always bottom of the list, behind even the employees whose improvident actions (that's being polite) caused the bankruptcy).
He will hope avidly and probably successfully that no one ever really follows the money, particularly his shark-jumping gift of $4 million to an off-shore private company and the issue of millions of cheap shares to his Aspire and Kips' Bay buddies.
It's penny stock grifting 101, and IPIX isn't Leo's first rodeo.
Spots, what do you think is happening here, if anything?
Were the Directors foolish to resign? Will CEO Leo Ehrlich ever be heard from again?
Will these be the last words the public ever hears from this Company?
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 31, 2024, Barry Schechter and Zorik Spektor each resigned from the Board of Directors of Innovation Pharmaceuticals Inc. (the “Company”), effective immediately. Their decisions to resign were not the result of any disagreement with the Company on any matter related to the Company’s operations, policies or practices.
Item 8.01 Other Events.
As previously disclosed, on January 22, 2020, the Company filed a complaint against Cummings Properties, LLC (“Cummings”) in the Superior Court of the Commonwealth of Massachusetts (C.A. No. 20-77CV00101), seeking, among other things, declaratory relief that the lease relating to the Company’s prior principal executive offices terminated in September 2018 rather than automatically extending for an additional five years. On August 29, 2023, the trial for this case commenced, and on January 18, 2024, the Court ruled in favor of Cummings, finding that Cummings is entitled to recover liquidated damages in the amount of $810,251.36, minus the Company’s $77,600 security deposit, plus eighteen percent per annum interest owing since January 17, 2020. The Company intends to appeal the decision.
You don’t own Brilacidin. You don’t own Beamed. Neither does IPIX. You’re a fool.
You’re pumping a ticker that isn’t even tradable.
IPIX is dead. You’re pumping a ticker that isn’t even tradable. Clown.
16000 posts who say all the same: Ipix is bad.
We can say 2 minutes to read a post. An other 2 minutes to write reply and find a new silly name for Mr. Ehrlich.
It is 64000 minutes. 1066 hours of work. Maybe much more.
All for a thing you say is nothing.
Days and weeks and months. You have Lost Them All.
"When positive news breaks, buying will be a free-for-all". LOL. Doubt there will be any positive news but how do you propose there to be a buying frenzy? Will the wasteland known as the "Expert" market suddenly open its gates for a day to accommodate this imaginary press release and allow this buying free for all? You are living in the land of make believe and lost investments. False hopes/ignore reality.
Maybe the recluse, Lost It All Leo, can do a Google Search press release. This debacle is an absolute disaster. If Brilacidin was as great as you believe it to be, this pile of junk would not be on life support. And given Error Prone Ehrlich's track record, I seriously doubt BeaMed will pull Ehrlich out of the sewer. If BeaMed is a great as you believe it to be, why would the Laser Boys sell such a large percentage to the idiot for $4 million - a lot for cash-strapped Ehrlich in a move that left his company with no funds but a pittance if the Laser Boys believed their product was a blockbuster. Doubt the Laser Boy would be so stupid. "A fool and his money......" Your IPIX portfolio must look like a nuclear bomb went off.
Nearly 5000 views already this morning on that message board, but practically no post activity for quite some time. The number of views ramping up so quickly tells me there is now a much greater awareness and interest in IPIX. The big question is why? Thousands of people are now checking in waiting for positive news to be announced, imo. I like that there is a minuscule number of shares being traded with no chance of any major accumulation as investors shares are not for sale. When positive news breaks, buying will be a free-for-all.
Innovation Pharmaceuticals now in top of the list of world Brilacidin patents when you look by publication date:
https://worldwide.espacenet.com/patent/search?q=brilacidin
Almost 100 new Brilacidin publication in Google Scholar for the last year:
https://scholar.google.com/scholar?as_sdt=40007&q=brilacidin&hl=en&scisbd=2
800 and more total:
https://scholar.google.com/scholar?hl=en&as_sdt=40007&q=brilacidin
This is what I own. Also a wee BeaMed. They add a COO in January.
It’s like a bad crash on the HWY, this wreck will have lots of casualties and everyone is watching.
People sure do like to rubber-neck.
"Just as there is no sensible reason to hold IPIX shares at this point."
Same as posting here multiple times daily on a "dead company".
And the sensible reason anyone would do that professor?
There isn't one. Just as there is no sensible reason to hold IPIX shares at this point.
I just checked 9050 views. I haven't looked at that site for many months. Thanks
And the sensible reason anyone would do that professor? Makes as much sense as a "shareholder" continuously disparaging a company on a daily basis. Because that would never hap...
"Intellectual curiosity" of course.
The BeaMed investment will make it entirely possible to see this scenario to fruition.
"Ipix will continue and sleep until after BeaMed asks USA FDA to approve the new laser system."
Some goober (probably goobers) discovered that you can add to the board view count by just refreshing the page. And you don't even have to be a board member to do it.
Even funnier is that you find that statistic meaningful.
PJ, I just checked and the IPIX views are now 6,522. That sort of activity demonstrates a huge amount of interest in this so-called "dead" company.
Views are now over 6100.....very strange....
E trade doesn’t sell anymore ..
There's no mention of it on the docket.
I don't know what "Review Appeals Filed" means.
When the item first appeared on the docket in April it said:
"Review Appeals Filed 03/11/2024 05/08/2024"
I believe that that was the basis for olden_grumpini's comment
Now it says:
"Review Appeals Filed 03/11/2024 06/12/2024"
IPIX filed a Notice of Appeal on 3/7 but that's just a statement of intent. An actual Appeal is a comprehensive filing providing a detailed basis.
I think.
o_g? Any thoughts?
My question is who is buying these shares that are now trading. The only answer I can come up with is; they are Market Makers who accecpeted short orders. All these trades are short coverings or closing out short positions. The stock wasen't totally delisted because there are still outstanding short positions, when those positions are all closed not sure what happens. Remember for every transaction there is a buyer and a seller; Buyer = short holder, seller = MM.
This is just my opinion.
I couldn't care less what come out of the echo chamber it's always been the same. Here's what we know. With fungal infection reported on the rise, the fact of the matter is we have a brand new patent app combining Bril with caspofungin, which together have shown to be an even more effective antifungal for combating life threatening infections.
"That is not cutting it....we all know that you all have an agenda on why you are really here......you can come clean sunny and just admit to it..."
"The appeal of the judgment against IPIX is due to be filed on May 8 (per court website). If that happens, it would be a signal to me that the CEO is still involved with IPIX.
You can check the court website yourself. Here are the directions: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164059214"
That is not cutting it....we all know that you all have an agenda on why you are really here......you can come clean sunny and just admit to it....
1) See my sticky.
2) To make fun of you.
Why do you and sunny spend so much time and energy on a dead company?? Why, why, why?????????
"Sure is a lot of views for a "dead company". 😁
How can this be?"
It's nonsense, obviously.
Logically, if these individuals really believed that IPIX is dead and worthless they would be gone... unless... their incentive for spending so much time here every day echoing their doom and gloom mantra is quite opposite from the content of the messages they post. Obviously, the answer is the latter of those two choices, imo.
Have you appealed to your broker Fidelity based on "accredited investor" status?
"The SEC defines an accredited investor as someone who meets one of the following three requirements:
Has an individual income of more than $200,000 per year, or a joint income of $300,000, in each of the last two years and expects to reasonably maintain the same level of income.
Has a net worth exceeding $1 million, either individually or jointly with his or her spouse.
Is a general partner, executive officer, director or a related combination thereof for the issuer of a security being offered."
https://www.bing.com/search?form=MOZLBR&pc=MOZR&q=%22accredited+investor%22+definition
Still trying to help in spite of your occasional insult. I figure if anyone deserves to own more shares of IPIX it's you.
Any news from court yesterday? Did IPIX actually show up for their appeal against a manifestly rock solid verdict against them?
Talk is cheap. The only thing cheaper - IPIX shares. .0004. Abysmal.
No communication with shareholders is unbelievable. Ehrlich is an absolute disgrace.
Lol. You win. Dumbest poster on this board.
Sure is a lot of views for a "dead company". 😁
How can this be?
Another IPIX board has had over 4000 views today and no posts since 4-19-2024!
I hope they're all long and strong holders who will not settle for peanuts.
This is a message board for discussion of Ipix for the good and bad and between. Social media activity on Ipix is a interesting subject. On a Ipix message board are 6 persons who "volunteer" and "moderate" discussion. For me for a long time it is interesting than 4 of these 6 say Ipix is nothing and is dead and is not worth talking about. Many times every day. Of course it is not logic. See smoke and sure there is fire.
The Brilacidin science and patent library continues to grow. I continue and look for how to buy more in a silly price.
2nd quarter is almost 1/2 over and not a word from bmed or Leo! No idea if it’s still on track to be approved! Hell we don’t even know if Leo has kept the partnership together or defaulted on it somehow! Do you have any info?
Yes. Ipix will continue and sleep until after BeaMed asks USA FDA to approve the new laser system. That will occur next month.
Sure is a lot of chatter for a "dead company". Hmmmm.
Carry on fellas. 😉
From your lips to God’s ears.
Pumper… you have no idea what is happening, you think posting that crsp is going to bring Leo your hero out of the hole? That dude is long gone…
Come on this POS is dead…
Followers
|
974
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
404115
|
Created
|
05/10/08
|
Type
|
Free
|
Moderators zandant sunspotter loanranger |
Innovation Pharmaceuticals Inc. (IPIX)
$IPIX NEWS - http://ipharminc.com/press-release
SEC Filings https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
From the most recent 10-K:
There are doubts about our ability to continue as a going concern.
We have generated revenue of $0 and $18,000 for the fiscal years ended June 30, 2023 and 2022, respectively and have an accumulated deficit of $125.3 million through June 30, 2023. These factors raise substantial doubt about our ability to continue as a going concern.
We need to raise substantial additional capital in the future to fund our operations and we may be unable to raise such funds when needed and on acceptable terms, which could prevent us from fully implementing our business, operating and development plans.
We currently have an approximate $1.0 million cash balance as of the date of this filing, but that is insufficient to complete the development and commercialization of any of our proposed products. We expect to incur costs of approximately $1.8 million in the upcoming fiscal year ending June 30, 2024 to operate our business in accordance with our business plans and budgets.
We have limited experience in drug and formulation development, the conduct of clinical trials, and may not be able to successfully develop any drugs.
Development of pharmaceutical products is a risky and time-consuming process subject to a number of factors, many of which are outside of our control. We are subject to regulatory authority permissions and approvals, most importantly the FDA. Our drug candidate(s)/indications are at early and mid-stages of development. Consequently, we can provide no assurance of the successful and timely development of new drugs, and the failure to do so could cause us to cease operations.
We may elect to deregister our common stock under the Exchange Act and suspend our reporting obligations. Such deregistration and suspension would result in less disclosure about us and may negatively affect the liquidity and trading prices of our common stock.
http://www.ipharminc.com/
About Innovation Pharmaceuticals Inc.:
Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.
Through ongoing research and drug development efforts, Innovation is focused on improving the clinical care of patients, as well as growing shareholder value. Our team consists of a diverse and accomplished group of professionals working together toward achieving this common goal.
IPIX CEO - "The Company historically devoted most of its efforts and resources on business development, regulatory matters, and clinical trials. Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully." "In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials." Source - https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223003414/ipix_10q.htm
More information is available at http://www.ipharminc.com.
Management: http://www.ipharminc.com/senior-management/
Scientific Advisors: http://www.ipharminc.com/scientific-advisors/
Clinical Trials: https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Product Pipeline: http://www.ipharminc.com/therapeutic-areas/
Recent News and Press Releases:
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/
SEC Filings (CIK:0001355250): https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com
Share Structure: See SEC filing link above for current share structure
Investor Relations:
http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1
Chart: https://stockcharts.com/h-sc/ui?s=IPIX
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |